BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21366452)

  • 1. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?
    Zembowicz A; Scolyer RA
    Arch Pathol Lab Med; 2011 Mar; 135(3):300-6. PubMed ID: 21366452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
    Collina G
    Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
    [No Abstract]   [Full Text] [Related]  

  • 3. Tertium non datur? Legitimacy of a third diagnostic category in melanocytic lesions.
    Urso C
    Arch Pathol Lab Med; 2012 Oct; 136(10):1181-3. PubMed ID: 23020718
    [No Abstract]   [Full Text] [Related]  

  • 4. Histogenetic categorization of atypical melanocytic tumor of uncertain biological malignant potential.
    Pusiol T
    An Bras Dermatol; 2018; 93(4):608-609. PubMed ID: 30066780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanocytic dysplasia and malignant melanoma. A critical review.
    Kwittken J
    J Med; 1991; 22(1):1-16. PubMed ID: 2072047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
    Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
    J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevus/melanocytoma/melanoma? Nosologic chaos.
    Miller DC
    Arch Pathol Lab Med; 2012 Feb; 136(2):135-6; author reply 136-7. PubMed ID: 22288954
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic nevus: why this term should be abandoned in dermatoscopy.
    Kittler H; Tschandl P
    Dermatol Clin; 2013 Oct; 31(4):579-88, viii. PubMed ID: 24075546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic lesions of the conjunctiva.
    Zembowicz A; Mandal RV; Choopong P
    Arch Pathol Lab Med; 2010 Dec; 134(12):1785-92. PubMed ID: 21128776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Nevus/melanocytoma/melanoma": that which we call a rose by any other name would smell as sweet.
    Sepehr A; Tahan SR
    Arch Pathol Lab Med; 2012 Feb; 136(2):135; author reply 136-7. PubMed ID: 22288955
    [No Abstract]   [Full Text] [Related]  

  • 13. Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulceration.
    Walters RF; Groben PA; Busam K; Millikan RC; Rabinovitz H; Cognetta A; Mihm MC; Prieto VG; Googe PB; King R; Moore DT; Woosley J; Thomas NE
    Am J Dermatopathol; 2007 Dec; 29(6):527-33. PubMed ID: 18032946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Melanocytoma, an intermediate entity between nevus and melanoma: implications of the WHO classification of melanocytic skin tumours].
    van den Broeke LR; Ebbelaar CF; Hayes DP; Bousema MT; Blokx WAM
    Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36988941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A classification of melanocytic dysplasias and malignant melanomas.
    Reed RJ
    Am J Dermatopathol; 1984; 6 Suppl():195-206. PubMed ID: 6528920
    [No Abstract]   [Full Text] [Related]  

  • 16. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
    Xavier-Junior JCC; Ocanha-Xavier JP
    Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocytic aggregation in the skin: diagnostic clues from lentigines to melanoma.
    de Giorgi V; Sestini S; Massi D; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):303-20, vii-viii. PubMed ID: 17662896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The approach to the patient with a difficult melanocytic lesion.
    Elder DE; Xu X
    Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.